Impact of extracellular polymeric substances on the settlement ability of aerobic granular sludgeHUAN CHEN; SHUNGUI ZHOU; TIANHONG LI et al.Environmental technology. 2010, Vol 31, Num 14, pp 1601-1612, issn 0959-3330, 12 p.Article

Effects of Ca²⁺ and Mg²⁺ on Defluoridafion in the Electrocoagulation ProcessHUAZHANG ZHAO; BIN ZHAO; WEI YANG et al.Environmental science & technology. 2010, Vol 44, Num 23, pp 9112-9116, issn 0013-936X, 5 p.Article

The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and CetuximabPEREZ-SOLER, Roman; YIYU ZOU; TIANHONG LI et al.Clinical cancer research (Print). 2011, Vol 17, Num 21, pp 6766-6777, issn 1078-0432, 12 p.Article

Skin toxicities associated with epidermal growth factor receptor inhibitorsTIANHONG LI; PEREZ-SOLER, Roman.Targeted oncology. 2009, Vol 4, Num 2, pp 107-119, issn 1776-2596, 13 p.Article

Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinibLING, Yi-He; TIANHONG LI; PEREZ-SOLER, Roman et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 3, pp 539-548, issn 0344-5704, 10 p.Article

Comparative Study of Phenolic Compounds and Antioxidant Activity in Different Species of CherriesYUN LIU; XINYAN LIU; FEI ZHONG et al.Journal of food science. 2011, Vol 76, Num 4, issn 0022-1147, C633-C638Article

Effect of Ca²⁺ and Na⁺ on the sorption of three selected endocrine disruptors to sedimentsWEILING SUN; JINREN NI; TIANHONG LI et al.Marine and freshwater research. 2009, Vol 60, Num 7, pp 767-773, issn 1323-1650, 7 p.Conference Paper

CTEN Prolongs Signaling by EGFR through Reducing Its Ligand-Induced DegradationHONG, Shiao-Ya; SHIH, Yi-Ping; TIANHONG LI et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 16, pp 5266-5276, issn 0008-5472, 11 p.Article

Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cellsTIANHONG LI; LING, Yi-He; GOLDMAN, I. David et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3413-3422, issn 1078-0432, 10 p.Article

Assessment of flooding impacts in terms of sustainability in mainland ChinaJINREN NI; LIYING SUN; TIANHONG LI et al.Journal of environmental management. 2010, Vol 91, Num 10, pp 1930-1942, issn 0301-4797, 13 p.Article

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group Trial (E1494)SPARANO, Joseph A; LEE, Sandra; CHEN, Michael G et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1491-1500, issn 0732-183X, 10 p.Article

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)TIANHONG LI; MENGYE GUO; GRADISHAR, William J et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 345-352, issn 0167-6806, 8 p.Article

Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade^®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)TIANHONG LI; HO, Liawaty; PIPERDI, Bilal et al.Lung cancer. 2010, Vol 68, Num 1, pp 89-93, issn 0169-5002, 5 p.Article

Caveolin-1 mutations in human breast cancer : Functional association with estrogen receptor α-positive statusTIANHONG LI; SOTGIA, Federica; VUOLO, Magalis A et al.The American journal of pathology. 2006, Vol 168, Num 6, pp 1998-2013, issn 0002-9440, 16 p.Article

Targeted inhibition of farnesyltransferase in locally advanced breast cancer : A phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamideSPARANO, Joseph A; MOULDER, Stacy; HOPKINS, Una et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 3013-3018, issn 0732-183X, 6 p.Article

Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer : SeleniumTIANHONG LI; WANCAI YANG; MAOMI LI et al.Molecular nutrition & food research (Print). 2008, Vol 52, Num 11, pp 1289-1299, issn 1613-4125, 11 p.Article

Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast CancerSPARANO, Joseph A; MOULDER, Stacy; MALAFA, Mokenge et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2942-2948, issn 1078-0432, 7 p.Article